Roche to buy InterMune By: MarketMinute » Stock News August 25, 2014 at 05:33 AM EDT Roche will pay a premium of approximately $8.3 billion in cash to purchase InterMune Inc. (Nasdaq: ITMN) sending the stock price surging $19.06 to $72.86.